Examining the Effectiveness of Combined Rehabilitation and Botulinum Toxin Injection on Functional Improvement of the Upper Limb After Stroke
Effectiveness of Botulinum Toxin Combined With Upper Limb Rehabilitation on Arm Function
1 other identifier
interventional
38
1 country
1
Brief Summary
The purpose of this study is to examine the effects of a combination of "Botulinum Toxin (BT) and Upper Limb (UL) rehabilitation" compared to "BT only" on UL motor function in adults with spasticity after stroke using a pre-post design. The research question is whether combination of BT and UL rehabilitation compared to BT only is more effective in improving the UL function, range of motion and pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 stroke
Started Jan 2012
Shorter than P25 for phase_3 stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 6, 2012
CompletedFirst Posted
Study publicly available on registry
January 19, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedJanuary 19, 2012
January 1, 2012
1.2 years
January 6, 2012
January 17, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified Ashworth
up tp 2013
Secondary Outcomes (1)
Goal attaiment Scale
up tp 2013
Study Arms (1)
upper limb rehabilitation for total of 6 months
EXPERIMENTALupper limb rehabiliation
Interventions
3 months upper rehabilation (twice a week) and then 3 more months upper limb rehabitation ( twice a week)
Eligibility Criteria
You may qualify if:
- over 18 years of age
- at least 4 months post stroke
- present with UL spasticity (MAS \>1 in elbow and/or spasticity of the hand, wrist or shoulder)
- present with at lease a stage 3 of CMSA
- able to comply with the requirements of the protocol and UL therapy programme.
You may not qualify if:
- significant cognitive and speech impairments
- other upper limb impairments such as frozen shoulder
- another diagnosis which could contribute to upper limb spasticity .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Toronto Rehabilitation Institutelead
- University of Torontocollaborator
Study Sites (1)
Toronto Rehabiliation institute
Toronto, Ontario, M5G 2A2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal inverstigator
Study Record Dates
First Submitted
January 6, 2012
First Posted
January 19, 2012
Study Start
January 1, 2012
Primary Completion
April 1, 2013
Study Completion
April 1, 2014
Last Updated
January 19, 2012
Record last verified: 2012-01